(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOVORIG

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NOVORIG

ST13

US500000090977298

Class

42

Filing

90977298

Registration

6863141

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

10/04/2022

Trademark type

Word

Nice classes

42

Filing date

08/13/2020

Registration date

10/04/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/04/2022

Last transaction

10/04/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

05/28/2020

First use in commerce

05/28/2020

Drawing code

4

Owner type

03

Owner location

Kitchener, Ontario, CA

Examiner

CUMMINS, LANCE

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Rapid Novor Inc.

Representatives

Jeffrey B. Sladkus, Esq. The Sladkus Law Group

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Development of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services

Publications

History of USPTO decisions and trademark events.

45 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/04/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/04/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/19/2022

PUBO

PUBLISHED FOR OPPOSITION

07/19/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/29/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/16/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/16/2022

ALIE

ASSIGNED TO LIE

06/15/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/13/2022

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

06/02/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/01/2022

GNSL

LETTER OF SUSPENSION E-MAILED

06/01/2022

CNSL

SUSPENSION LETTER WRITTEN

06/01/2022

IUAA

USE AMENDMENT ACCEPTED

06/01/2022

DPCC

DIVISIONAL PROCESSING COMPLETE

05/31/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/31/2022

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

05/03/2022

IUAF

USE AMENDMENT FILED

05/03/2022

DRRR

DIVISIONAL REQUEST RECEIVED

05/03/2022

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

05/03/2022

EAAU

TEAS AMENDMENT OF USE RECEIVED

05/03/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/03/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

11/05/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

11/05/2021

CNSI

SUSPENSION INQUIRY WRITTEN

11/05/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/05/2021

GNSL

LETTER OF SUSPENSION E-MAILED

05/05/2021

CNSL

SUSPENSION LETTER WRITTEN

05/05/2021

DOCK

ASSIGNED TO EXAMINER

04/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/23/2021

ALIE

ASSIGNED TO LIE

03/18/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/16/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/14/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/14/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/14/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/14/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/14/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/08/2020

GNRT

NON-FINAL ACTION E-MAILED

12/08/2020

CNRT

NON-FINAL ACTION WRITTEN

12/08/2020

DOCK

ASSIGNED TO EXAMINER

12/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/17/2020

Continuous trademark protection

Get notified about every new filing that threatens NOVORIG or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.